Skip to main content
Fig. 4 | BMC Genomics

Fig. 4

From: Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients

Fig. 4

Development of the disulfidptosis-related prognostic signature (DR score). A The expression profiles of 13 DGs between the low- and high-risk group in the TCGA cohort. B Difference of DR scores between two DGs clusters. C-D The heatmap includes clinicopathological features and expression profiles of 8 OS-genes in the TCGA and E-MTAB-1980 cohort, respectively. E-G The distribution of DGs scores and survival status in the TCGA, E-MTAB-1980, Braun cohort, respectively. *P < 0.05, **P < 0.01, ***P < 0.001, ns: no significance

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us